Paired Anti-Obesity Drugs May Help Teens Shed More Weight After Metabolic Surgery But phentermine/topiramate dose could be limited by side effects, researcher says Nov 07, 2021
Liraglutide After Gastric Bypass Helped Stave Off Weight Regain The GLP-1 receptor agonist kept patients closer to nadir weight versus lifestyle management alone Nov 04, 2021
Ghrelin Aids Weight Loss; FDA Says Cut Salt; More Bariatric Surgeries With Medicaid News and commentary from the endocrinology world Oct 17, 2021
Birth Control Pills May Curb PCOS-Related Diabetes Risk Retrospective results lay groundwork for potential preventive treatment option Oct 14, 2021
Fewer Deaths After Sleeve Gastrectomy Versus Gastric Bypass Authors estimate about 540 fewer deaths at 5 years if all patients chose sleeve Oct 06, 2021
Diabetes Risk With Breastmilk, Antidepressants, Weight Loss A roundup of noteworthy research from the EASD 2021 meeting Oct 04, 2021
Healthy Lifestyle Keeps Dementia at Bay in Patients With Diabetes Maintaining control of risk factors neutralized excess dementia risk Sep 29, 2021
$8B Price Tag for PCOS; Tymlos Label Update; Genetic Obesity Tx Seeks New Approvals News and commentary from the endocrinology world Sep 26, 2021
Prediabetes Tied to Doubled Risk of Major Depression in Dutch Study Check metabolic status of those with mood disorders and vice versa, researcher says Sep 23, 2021
Long-Term Costs, Outcomes of Sleeve Gastrectomy vs Roux-en-Y Unexpected findings in large-scale 4-year Canadian study Sep 09, 2021
ADT Options for Prostate Cancer Come Out Even for Heart Safety But low enrollment brought PRONOUNCE trial to an early close Aug 31, 2021
Combo GIP/GLP-1 Injectable Beats Insulin for A1c Reduction All doses of once-weekly tirzepatide better than insulin degludec for HbA1c reduction Aug 11, 2021
HIV Independently Tied to More Severe COVID-19 WHO analysis also shows higher risk for inhospital mortality Jul 18, 2021
Vascular Function: Another Benefit of Bariatric Surgery Macrovascular, microvascular gains accrue for nearly all patient groups Jul 12, 2021
Academic Cardiologists Singled Out for Gender Equality Problem Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
Resmetirom Delivers Promising Outcomes in NASH Without Invasive Follow-Up Real-world study also identifies noninvasive markers for treatment response Jun 29, 2021
Combo GIP/GLP-1 Drug Superior for HbA1c Reduction in T2D 40-week trial compared tirzepatide head-to-head with injectable semaglutide Jun 25, 2021
What Leads to Patients With Diabetes Relapsing After Bariatric Surgery? Risk factors included longer diabetes duration, higher preop HbA1c in Swedish study Jun 14, 2021
Nearly a Five-Fold Difference Between States in Use of Bariatric Surgery Weight loss procedure underutilized in areas with highest obesity prevalence Jun 13, 2021
Patients with Class I Obesity Still Benefit from Weight-Loss Surgery It may be time to update NIH-established indications for bariatric surgery, experts say Jun 12, 2021
COVID-19 in Diabetes: What Mediates Risk? Certain clinical factors tied to higher chance of severe infection May 28, 2021
FDA Draft Guidance on T2D Devices; New GLP-1 Drug Succeeds in Trial News and commentary from the endocrinology world May 23, 2021
Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment Endoscopic procedure could yield benefits now seen only with more invasive surgery May 14, 2021
Amylin Analogue Plus Semaglutide Get Early Win for Weight Loss Combining agents yielded greater weight changes than semaglutide alone May 13, 2021
Saxenda Boosted Weight Loss, Especially With Exercise But year-long RCT excluded those with type 2 diabetes May 05, 2021
Tepezza Restock Coming; Osteoporotic Fractures Broken Down by State News and commentary from the endocrinology world Apr 04, 2021
Transgender Youth at Risk for Poorer Heart Health Association could be attributed to gender-affirming hormone therapy, researcher says Mar 23, 2021
Maintenance Semaglutide Keeps Shedding the Pounds Continued weight loss beyond 1 year while on drug; patients switched to placebo gained it back Mar 23, 2021
Another Weight-Loss Trial Win for Weekly GLP-1 Drug Effective in diabetic patients with BMI as low as 27 Mar 05, 2021
GIP/GLP-1 RA Phase III Success; USPSTF Looking for Input News and commentary from the endocrinology world Feb 28, 2021
White Bread or White Rice? Glycemic Index Telling of CVD Risk Across Borders Observational study suggests role of diet in primary, secondary prevention alike Feb 24, 2021
Semaglutide Shines as Weight Loss Therapy "Unprecedented results" for patients with obesity in 68-week trial Feb 10, 2021
Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids? News and commentary from the endocrinology world Jan 24, 2021
Monoclonal Antibody Induces Weight Loss in Type 2 Diabetes Phase II trial reported decreased fat, increased lean mass Jan 13, 2021
Growth Hormones in Childhood Tied to Heart Problems Later On Women, those who were small for gestational age at highest risk Dec 21, 2020
New GLP-1 Agonist Succeeds in Phase III; PFAS Chemicals & COVID-19 News and commentary from the endocrinology world Dec 11, 2020
Controversial Diabetes Clinic Owner to Pay Doc $8M in Damages Decision in 9-year lawsuit paves way for injunction against diabetes clinics Nov 19, 2020
IBT Plus Semaglutide Slashed Pounds, CVD Risk Patients lost 16% of body weight after 68 weeks in phase III trial Nov 09, 2020